IBOGAINE DRUG DEVELOPMENT
CREATING THE GOLD STANDARD FOR ADDICTION TREATMENT
State of the Art Holistic Care Clinics
We aim to provide those living with addiction improved treatment outcomes, introducing ibogaine as a central piece of the solution.
MISSION
To treat the roots of addiction effectively using ibogaine in a state of the art holistic clinical setting.
VISION
Provide those living with addiction the best possible recovery treatment to enable them to be free from addiction and to flourish.
OBJECTIVE
Universal Ibogaine offers an opportunity to help tackle the scourge of addiction. We present an ethical, medically-supervised and regulatory sanctioned channel to participate in the PSYCHEDELICS space.
OUR WHY
TEAM
OPIOID CRISIS: OUR WHY
The crisis breakdown in numbers.
2 HR
The average time that passes between deaths in Canada by illicit drug overdose
20%
The percentage of Canadian adults suffering from addiction
90%
The relapse rate associated with current treatment modalities
93%
Increase in overdose deaths amongst First Nations communities in BC (2019-2020)
$600 Billion
Annual economic impact from alcohol and drug addiction in USA
#1
Overdose is the leading cause of accidental death in North America for people under 50
395%
Annual Increase in Substance Abuse Deaths worldwide since 1999
$ 2.93 Trillion
The cost of the Opioid Crisis in the USA from 2015-2018
35 Million
The number of people receiving treatment for addiction in treatment centres
OUR SOLUTION
Creating the Gold Standard for Addiction Treatment
State of the Art Holistic Care Clinics Introducing Medical Ibogaine as a Central Pillar of Disease Management
Ibogaine targets multiple receptor sites in the brain, stimulates the production of neural growth factor (enabling the production of new dopamine cells) and resets the central nervous system.
Paired with our treatment protocol ibogaine alleviates withdrawal symptoms and interrupts the process of active addiction.
Ibogaine’s long-lasting metabolite decreases or eliminates cravings and removes the overwhelming compulsion to use drugs for approximately 2-4 months following treatment.
Ibogaine is a naturally occurring psychoactive substance found in various plants. Ibogaine is broad spectrum agonizer that targets multiple receptor sites in the brain.
Ibogaine has been shown to rebuild opioid receptor sites and return the brain to an opioid naïve state with as little as one dose.
OUR CLINICS
Universal Ibogaine is developing a network of state of the art clinics.
More Information on our Treatment Clinics.
TESTIMONIALS & VIDEOS TO WATCH
OPERATIONAL MILESTONES
The road ahead is long. Our balance between medical expertise, corporate know-how, and capital markets understanding means we are well set for success.
INITIAL PUBLIC OFFERING
For information on our public listing process, please visit our investor relations page, or contact us.
We have completed our Subscription Receipt Qualifying Transaction. We will be trading on the TSX Venture Exchange, symbol IBO.
Being publicly owned allows everyone to be a part of the solution and enables us to obtain required financing for drug development and clinic expansion.
IBOGAINE
events
IBOGAINE
media
Opioid epidemic: the medical industry created a public health crisis | Chris Johnson, MD | TEDxEdina
News
articles
P SQUARED RENEWABLES INC. ANNOUNCES THE COMPLETION OF QUALIFYING TRANSACTION AND THE PRIOR CLOSING OF $6 MILLION SUBSCRIPTION RECEIPT FINANCING
Universal Ibogaine and PSQ are pleased to announce the completion of the Qualifying Transaction, closing the $6 million subscription receipt financing.
P SQUARED RENEWABLES INC. AND UNIVERSAL IBOGAINE INC. ANNOUNCE FILING OF FILING STATEMENT ON SEDAR
Universal Ibogaine and PSQ are pleased to announce that PSQ has SEDAR filed…
P SQUARED RENEWABLES INC. AND UNIVERSAL IBOGAINE INC. ANNOUNCE TSX.V CONDITIONAL APPROVAL OF QUALIFYING TRANSACTION
Calgary, Alberta – P Squared Renewables Inc. (TSXV: PSQ.P) (“PSQ” or the “Company“) a capital